(Q45155837)

10 December 2017

Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration (English)

1 reference

10 December 2017

Surya P Ayalasomayajula

series ordinal

1

1 reference

10 December 2017

Uday B Kompella

2

1 reference

10 December 2017

1 October 2004

1 reference

10 December 2017

Pharmaceutical Research

1 reference

10 December 2017

21

1 reference

10 December 2017

10

1 reference

10 December 2017

1797-1804

1 reference

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

10 December 2017

1 reference

12 December 2020

Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide

1 reference

12 December 2020

Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line

1 reference

12 December 2020

Cardiovascular and renal effects of COX-2-specific inhibitors: recent insights and evolving clinical implications

1 reference

12 December 2020

Ocular pharmacokinetics of dacarbazine following subconjunctival versus intravenous administration in the rabbit

1 reference

12 December 2020

Subconjunctival doxifluridine administration suppresses rat choroidal neovascularization through activated thymidine phosphorylase

1 reference

12 December 2020

Macrophage depletion inhibits experimental choroidal neovascularization

1 reference

12 December 2020

Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice

1 reference

12 December 2020

High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.

1 reference

12 December 2020

Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye

1 reference

12 December 2020

Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection

1 reference

12 December 2020

Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics

1 reference

12 December 2020

Needle penetration of the globe during retrobulbar and peribulbar injections

1 reference

12 December 2020

Effects of subconjunctivally injected antineoplastic agents on three models of corneal inflammation

1 reference

12 December 2020

Role of vascular endothelial growth factor in diabetic vascular complications

1 reference

12 December 2020

Transscleral drug delivery for posterior segment disease

1 reference

12 December 2020

Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat.

1 reference

12 December 2020

Review: practical issues in intravitreal drug delivery

1 reference

12 December 2020

Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression

1 reference

12 December 2020

Pharmacokinetics of celecoxib in the presence and absence of interferon-induced acute inflammation in the rat: application of a novel HPLC assay.

1 reference

12 December 2020

Oral erythromycin treatment for childhood blepharokeratitis

1 reference

12 December 2020

Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose

1 reference

12 December 2020

Importance of the noncorneal absorption route in topical ophthalmic drug delivery

1 reference

12 December 2020

Penetration into the anterior chamber via the conjunctival/scleral pathway

1 reference

12 December 2020

Ocular pharmacokinetics of subconjunctivally versus intravenously administered 6-mercaptopurine

1 reference

12 December 2020

The discovery and function of COX-2.

1 reference

12 December 2020

Characterization of adenovirus p21 gene transfer, biodistribution, and immune response after local ocular delivery in New Zealand white rabbits

1 reference

12 December 2020

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

1 reference

12 December 2020

A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability

1 reference

12 December 2020

Penetration of amikacin into aqueous humor of rabbits

1 reference

12 December 2020

Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

1 reference

12 December 2020

Diffusion of high molecular weight compounds through sclera

1 reference

12 December 2020

Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases

1 reference

12 December 2020

Anti-angiogenic therapy of proliferative diabetic retinopathy

1 reference

12 December 2020

Oral ketoconazole in Keratomycosis

1 reference

12 December 2020

Oral acyclovir in the management of dendritic herpetic corneal ulceration

1 reference

12 December 2020

Renal failure associated with the use of celecoxib and rofecoxib

1 reference

12 December 2020

Expression of cyclooxygenase-1 and -2 mRNA in rat tissues: tissue-specific difference in the expression of the basal level of mRNA

1 reference

12 December 2020

Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis

1 reference

12 December 2020

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

12 December 2020

10.1023/B:PHAM.0000045231.51924.E8

Identifiers

DOI

1 reference

10 December 2017

1 reference

PubMed ID

15553225